<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font21 { font-size : 21; } .font24 { font-size : 24; } .font29 { font-size : 29; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font29">and </span>
   <span class="font24">with </span>
   <span class="font21">patients </span>
   <span class="font18">have </span>
   <span class="font17">for </span>
   <span class="font16">HCC </span>
   <span class="font15">HCV </span>
   <span class="font15">after </span>
   <span class="font14">(.–.) </span>
   <span class="font14">has </span>
   <span class="font14">{background </span>
   <span class="font14">SVR </span>
   <span class="font13">been </span>
   <span class="font13">are </span>
   <span class="font13">margin </span>
   <span class="font13">treatment </span>
   <span class="font13">al. </span>
   <span class="font13">liver </span>
   <span class="font13">{border-style </span>
   <span class="font13">antiviral </span>
   <span class="font13">hepatitis </span>
   <span class="font13">cirrhosis </span>
   <span class="font13">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">;():–. </span>
   <span class="font12">months </span>
   <span class="font12">that </span>
   <span class="font12">hepatocellular </span>
   <span class="font12">who </span>
   <span class="font12"> Median </span>
   <span class="font12">(range) </span>
   <span class="font12">The </span>
   <span class="font12">study </span>
   <span class="font12"> Mean </span>
   <span class="font12">Patients </span>
   <span class="font12">carcinoma </span>
   <span class="font12">from </span>
   <span class="font12">occurrence </span>
   <span class="font12">significant </span>
   <span class="font11">(.%) </span>
   <span class="font11">Treatment </span>
   <span class="font11">direct-acting </span>
   <span class="font11">improvement </span>
   <span class="font11">infection </span>
   <span class="font11">treated </span>
   <span class="font11">treatment. </span>
   <span class="font11">about </span>
   <span class="font11">high </span>
   <span class="font11">this </span>
   <span class="font11">virus </span>
   <span class="font11">without </span>
   <span class="font11">hepatic </span>
   <span class="font11">MELD </span>
   <span class="font11">Mean </span>
   <span class="font11">incidence </span>
   <span class="font11">not </span>
   <span class="font11">occurred </span>
   <span class="font11">px; </span>
   <span class="font11">rate </span>
   <span class="font11">{font-family </span>
   <span class="font11">(n= </span>
   <span class="font11">Assiut </span>
   <span class="font11">Liver </span>
   <span class="font11">diabetes </span>
   <span class="font11">end </span>
   <span class="font11">first </span>
   <span class="font11">font-size </span>
   <span class="font11">increased </span>
   <span class="font11">may </span>
   <span class="font11">patients. </span>
   <span class="font11">risk </span>
   <span class="font11">sustained </span>
   <span class="font11">therapy </span>
   <span class="font11">those </span>
   <span class="font11">virological </span>
   <span class="font11">were </span>
   <span class="font11">After </span>
   <span class="font11">Child </span>
   <span class="font11">HCV-related </span>
   <span class="font11">Hepatol. </span>
   <span class="font11">Non-SVR </span>
   <span class="font11">This </span>
   <span class="font11">University </span>
   <span class="font11">before </span>
   <span class="font11">data </span>
   <span class="font11">developed </span>
   <span class="font11">done </span>
   <span class="font11">double; </span>
   <span class="font11">follow-up </span>
   <span class="font11">non-SVR </span>
   <span class="font11">our </span>
   <span class="font11">response </span>
   <span class="font11">value </span>
   <span class="font11">while </span>
   <span class="font10">AFP </span>
   <span class="font10">Abbreviations: </span>
   <span class="font10">Alrajhi </span>
   <span class="font10">Characteristics </span>
   <span class="font10">Hepatology. </span>
   <span class="font10">PCR </span>
   <span class="font10">SVR, </span>
   <span class="font10">Table </span>
   <span class="font10">achieved </span>
   <span class="font10">advanced </span>
   <span class="font10">all </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">but </span>
   <span class="font10">chronic </span>
   <span class="font10">cohort </span>
   <span class="font10">development </span>
   <span class="font10">due </span>
   <span class="font10">eradication </span>
   <span class="font10">every </span>
   <span class="font10">his </span>
   <span class="font10">history </span>
   <span class="font10">major </span>
   <span class="font10">mean </span>
   <span class="font10">median </span>
   <span class="font10">more </span>
   <span class="font10">response; </span>
   <span class="font10">ribavirin </span>
   <span class="font10">sofosbuvir </span>
   <span class="font10">solid; </span>
   <span class="font10">used </span>
   <span class="font10">which </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">;:–. </span>
   <span class="font10">Ascites </span>
   <span class="font10">Before </span>
   <span class="font10">Clinical </span>
   <span class="font10">DAAs </span>
   <span class="font10">Direct-acting </span>
   <span class="font10">Egypt </span>
   <span class="font10">HCC, </span>
   <span class="font10">HCC. </span>
   <span class="font10">Hassany </span>
   <span class="font10">Hepatocellular </span>
   <span class="font10">Hepatoma </span>
   <span class="font10">March </span>
   <span class="font10">P-value </span>
   <span class="font10">Res. </span>
   <span class="font10">abdominal </span>
   <span class="font10">also </span>
   <span class="font10">antivirals </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">cancer </span>
   <span class="font10">colleagues </span>
   <span class="font10">compensated </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">daclatasvir </span>
   <span class="font10">doi:./hep. </span>
   <span class="font10">doi:./j.jhep... </span>
   <span class="font10">em; </span>
   <span class="font10">found </span>
   <span class="font10">genotype </span>
   <span class="font10">had </span>
   <span class="font10">including </span>
   <span class="font10">levels </span>
   <span class="font10">management </span>
   <span class="font10">non-SVR. </span>
   <span class="font10">papers </span>
   <span class="font10">patient </span>
   <span class="font10">phase, </span>
   <span class="font10">plus </span>
   <span class="font10">population </span>
   <span class="font10">possible </span>
   <span class="font10">prospective </span>
   <span class="font10">pt;} </span>
   <span class="font10">recurrence </span>
   <span class="font10">score </span>
   <span class="font10">scores </span>
   <span class="font10">shown </span>
   <span class="font10">since </span>
   <span class="font10">studied </span>
   <span class="font10">studies, </span>
   <span class="font10">study. </span>
   <span class="font10">type </span>
   <span class="font10">where </span>
   <span class="font10">work </span>
   <span class="font10">year </span>
  </p>
 </body>
</html>
